Hospital Italiano de Buenos Aires
hospitalitaliano.org.arLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
128
Active
18
Phase 3
5
Total enrollment
14,153,810
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ketamine | — | — | — | — | 2 | ||
| semaglutide | — | — | — | — | — | 1 |
Next readouts
- 2027-07-01
- 2027-12-31
Top conditions
- COVID-195
- COPD5
- Multiple Sclerosis3
- Bacterial Infections3
- Carpal Tunnel Syndrome3
- Death3
- Covid193
- Appointments and Schedules3
Frequently asked questions about Hospital Italiano de Buenos Aires
- How many clinical trials does Hospital Italiano de Buenos Aires have on ClinicalTrials.gov?
- Hospital Italiano de Buenos Aires is listed as the lead sponsor on 128 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hospital Italiano de Buenos Aires's trials are in Phase 3?
- 5 of Hospital Italiano de Buenos Aires's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Hospital Italiano de Buenos Aires focus on?
- Hospital Italiano de Buenos Aires's most-studied conditions on ClinicalTrials.gov are COVID-19, COPD, Multiple Sclerosis, Bacterial Infections, Carpal Tunnel Syndrome.
- When are Hospital Italiano de Buenos Aires's next clinical trial readouts?
- Hospital Italiano de Buenos Aires has 2 upcoming primary-completion readouts tracked here; the soonest is “Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients”, expected around 2027-07-01.